Rossi Christina
SEC insider (Form 3/4/5 filer). CIK 0001756941. Director at CG Oncology, Inc. (CGON) and 2 other issuers. 25 reported Form 4/5 transactions since Sep 2024; latest on Jun 4, 2026. Located in DALLAS, TX.
Companies Rossi Christina has filed insider reports for
- CG Oncology, Inc. (CGON): Director
- Blueprint Medicines Corp (BPMC): Officer, CHIEF OPERATING OFFICER
- Xilio Therapeutics, Inc. (XLO): Director
Rossi Christina
CIK: 0001756941
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (25 total)
- Jun 4, 2026CGON
CG Oncology, Inc.
AwardDirectDirector Stock Option (right to buy)
9.4K shares- - Nov 24, 2025CGON
CG Oncology, Inc.
AwardDirectDirector Stock Option (right to buy)
20.9K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
Tender OfferDirect20.6K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
DispositionDirect82.4K shares- - Jul 17, 2025BPMC
Blueprint Medicines Corp
AwardDirect39.5K shares- - Jul 3, 2025BPMC
Blueprint Medicines Corp
SaleDirect1.2K shares at avg. $128.25$150K - Jun 11, 2025XLO
Xilio Therapeutics, Inc.
AwardDirectStock Option (right to buy)
31K shares- - May 19, 2025BPMC
Blueprint Medicines Corp
SaleDirect57 shares at avg. $101.72$6K - May 19, 2025BPMC
Blueprint Medicines Corp
SaleDirect1.4K shares at avg. $100.67$142K - May 19, 2025BPMC
Blueprint Medicines Corp
SaleDirect804 shares at avg. $100.14$81K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 4, 2026 |  CGON CG Oncology, Inc. | Award Director Stock Option (right to buy) | 9,354 | - | - | Direct |
| Nov 24, 2025 | CGON CG Oncology, Inc. | Award Director Stock Option (right to buy) | 20,889 | - | - | Direct |
| Jul 17, 2025 |  BPMC Blueprint Medicines Corp | Tender Offer | 20,628 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Disposition | 82,374 | - | - | Direct |
| Jul 17, 2025 | BPMC Blueprint Medicines Corp | Award | 39,456 | - | - | Direct |
| Jul 3, 2025 | BPMC Blueprint Medicines Corp | Sale | 1,172 | $128.25 | $150,309 | Direct |
| Jun 11, 2025 |  XLO Xilio Therapeutics, Inc. | Award Stock Option (right to buy) | 31,000 | - | - | Direct |
| May 19, 2025 | BPMC Blueprint Medicines Corp | Sale | 57 | $101.72 | $5,798 | Direct |
| May 19, 2025 | BPMC Blueprint Medicines Corp | Sale | 1,413 | $100.67 | $142,247 | Direct |
| May 19, 2025 | BPMC Blueprint Medicines Corp | Sale | 804 | $100.14 | $80,513 | Direct |
1-10 of 25 transactions